Author | random allocation | allocation concealment | blind method | withdraw | Jadad score | Interventions | Duration | Outcomes | |
experimental | control | ||||||||
Yu 2010 [9] | yes | unclear | unclear | unclear | 3 | GSZT | MTX 7.5 mg qw, SSZ 1 g bid | 12 weeks | TE, DMS, ESR, CRP, AE |
Liu 2008 [10] | unclear | unclear | unclear | unclear | 2 | GSZT | MTX 7.5 mg qw, MLX7.5 mg bid | 4 weeks | TE |
Liu 2008 [11] | unclear | unclear | unclear | unclear | 2 | GSZT | LEF 20 mg qd | 4 weeks | TE |
Lv 2014 [12] | yes | unclear | unclear | unclear | 3 | GSZT | MTX 7.5 mg qw, voltaren 75 mg qd | 12 weeks | TE, ESR, RF, AE |
Zhang 2017 [13] | yes | unclear | unclear | yes | 4 | GSZT | LEF 20 mg qd, Nime 0.1 g bid | 12 weeks | TE, DMS, ESR, RF, CRP |
Yang 2016 [14] | unclear | unclear | unclear | unclear | 2 | GSZT | CXB 0.2 g qd | 12 weeks | TE |
Tian 2011 [15] | unclear | unclear | unclear | unclear | 2 | GSZT | NSAIDs, GCs | 8 weeks | TE, DMS, ESR |
Xiao 2012 [16] | unclear | unclear | unclear | unclear | 2 | GSZT | MTX 5 10 mg qw, voltaren 75 mg qd | 12 weeks | TE, ESR |
Chen 2017 [17] | yes | unclear | unclear | unclear | 3 | GSZT | MTX 10 mg qw, voltaren 75 mg qd | 12 weeks | TE, DMS, ESR, RF, CRP, AE |
Liu 2017 [18] | yes | unclear | unclear | unclear | 3 | GSZT | LEF 20 mg qd, loxoprofen 60 mg tid | 8 weeks | ESR, RF, CRP |